Disciplined Growth Investors’s Redhill Biopharma RDHL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-811	Closed	-$705K	–	74
2022 Q2	$705K	Sell	811 -1,139	-58%	-$1.56M	0.02%	70
2022 Q1	$4.91M	Buy	1,950 +14	+0.7%	+$33.2K	0.11%	63
2021 Q4	$4.99M	Sell	1,936 -40	-2%	-$160K	0.1%	62
2021 Q3	$9.05M	Hold	1,976	–	–	0.18%	60
2021 Q2	$13.6M	Buy	1,976 +147	+8%	+$1.01M	0.26%	57
2021 Q1	$13.4M	Sell	1,829 -200	-10%	-$1.68M	0.27%	55
2020 Q4	$16.4M	Sell	2,029 -82	-4%	-$737K	0.32%	55
2020 Q3	$21.6M	Sell	2,111 -7	-0.3%	-$57.4K	0.51%	50
2020 Q2	$14.2M	Buy	2,118 +414	+24%	+$2.85M	0.34%	56
2020 Q1	$7.72M	Sell	1,704 -148	-8%	-$740K	0.18%	61
2019 Q4	$11.2M	Buy	1,852 +707	+62%	+$4.52M	0.19%	63
2019 Q3	$8.06M	Buy	1,145 +5	+0.4%	+$36.4K	0.15%	67
2019 Q2	$7.41M	Sell	1,140 -10	-0.9%	-$77K	0.14%	67
2019 Q1	$9.56M	Buy	1,150 +7	+0.6%	+$55.4K	0.17%	67
2018 Q4	$6.34M	Buy	1,143 +1,110	+3,364%	+$8.51M	0.13%	72
2018 Q3	$295K	Buy	+33	New	+$269K	﹤0.01%	86